PCRX and VTRS Related Headlines
Go Back- Jefferies Downgrades Pacira Pharmaceuticals (PCRX) to Hold
- Viatris to acquire Pacira BioSciences for $1.65 billion
- Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies


